Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;9(3):542-549.
doi: 10.14283/jpad.2022.32.

Site Readiness Framework to Improve Health System Preparedness for a Potential New Alzheimer's Disease Treatment Paradigm

M Anderson  1 , N Sathe, C Polacek, J Vawter, T Fritz, M Mann, P Hernandez, M C Nguyen, J Thompson, J Penderville, M Arling, S Safo, R Christopher
Affiliations

Site Readiness Framework to Improve Health System Preparedness for a Potential New Alzheimer's Disease Treatment Paradigm

M Anderson et al. J Prev Alzheimers Dis. 2022.

Abstract

New therapies that address the underlying pathophysiology of Alzheimer's Disease (AD), coupled with the growth of the AD population, will transform the AD care pathway and present significant challenges to health systems. We explored real-world challenges health systems may face in delivering potential new AD therapies with diverse stakeholders. Key challenges in care included integrating primary care providers into assessment and management, availability of memory care specialists, understanding payment and coverage issues and training mid-level providers to help coordinate care and serve as a shared resource across the system. This input informed a novel Site Readiness Framework for AD, comprising self-assessment exercises to identify health system capabilities and gaps and a framework of core strategies and responsive tools to help prepare to integrate new AD therapies. These resources may help health systems improve readiness to modify care pathways to integrate new therapies for AD.

Keywords: Alzheimer's diease; care pathways; mild cognitive impairment; new therapies; site readiness framework.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Project Approach
Figure 2
Figure 2
Framework Example
Figure 3
Figure 3
Care Coordination Readiness Checklist
Figure 4
Figure 4
Archetype Models
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Gauthier S, Rosa-Neto P, Morais JA. World Alzheimer’s Report 2021. Accessed January 31, 2022. https://www.alzint.org/resource/world-alzheimer-report-2021/
    1. Holtzman DM, Morris JC, Goate AM. Alzheimer’s disease: the challenge of the second century. Sci Transl Med. 2011;3(77):77sr1. doi: 10.1126/scitranslmed.3002369. - DOI - PMC - PubMed
    1. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. Mar. 2001;58(3):397–405. - PubMed
    1. Alzheimer’s Association Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17(3):327–406. doi: 10.1002/alz.12328. - DOI - PubMed
    1. Rajan K, Wilson R, Weuve J, Barnes L, Evans D. Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia. Neurology. 2015;85(10):898–904. doi: 10.1212/WNL.0000000000001774. - DOI - PMC - PubMed

Publication types